NF-L has been regarded as a biomarker of neurologic damage in disease states such as amyotrophic lateral sclerosis, diabetes, and Parkinson's disease and increases with neurotoxic chemotherapy [13, 14]. Here, NEFL is linked to amyotrophic lateral sclerosis.